Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “β-catenin”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Early research (Phase 1)Study completedNCT01764477
What this trial is testing

Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Advanced Pancreatic CancerMetastatic Pancreatic CancerPancreatic Adenocarcinoma
Prism Pharma Co., Ltd. 20
Not applicableActive Not RecruitingNCT05544396
What this trial is testing

Study on the Probiotics Regulating miRNA in H. Pylori-induced Wnt/β-catenin Gastric Carcinogenesis.

Who this might be right for
H. Pylori InfectionCarcinogenesis
National Cheng-Kung University Hospital 100
Early research (Phase 1)Study completedNCT04047160
What this trial is testing

Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)

Who this might be right for
Primary Biliary Cholangitis (PBC)Liver Cirrhosis, Biliary
Kiminori Kimura, MD 7
Testing effectiveness (Phase 2)Study completedNCT03620474
What this trial is testing

Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis

Who this might be right for
Hepatitis CHepatitis BLiver Cirrhoses
Kiminori Kimura, MD 27
Not applicableStudy completedNCT02137421
What this trial is testing

A Case Control Study of Resveratrol Effects in Coronary Artery Disease Patients With Metabolic Syndrome

Who this might be right for
Metabolic SyndromeCoronary Artery Disease
Tehran University of Medical Sciences 20
Testing effectiveness (Phase 2)Looking for participantsNCT06811116
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial

Who this might be right for
Advanced Hepatocellular CarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8+1 more
National Cancer Institute (NCI) 92
Testing effectiveness (Phase 2)Looking for participantsNCT05919264
What this trial is testing

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Who this might be right for
CancerColorectal CancerSolid Tumor+17 more
Parabilis Medicines, Inc. 575
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05688241
What this trial is testing

EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases

Who this might be right for
EBV LymphomaPost-transplant Lymphoproliferative Disease (PTLD)
University Hospital, Basel, Switzerland 10
Not applicableActive Not RecruitingNCT07245225
What this trial is testing

Acute Effects of High Impact Exercise on Bone Metabolism

Who this might be right for
Health Adults
Loughborough University 15
Testing effectiveness (Phase 2)Study completedNCT02077777
What this trial is testing

Chemopreventive Action of Mesalazine on Colorectal Cancer: a Pilot Study for an "in Vivo" Evaluation of the Molecular Effects on β-catenin Signaling Pathway.

Who this might be right for
Colorectal Cancer
SOFAR S.p.A. 21